- Home
- ADI vs ABT Comparison
ADI vs ABT Comparison
Compare ADI & ABT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ADI | ABT |
|---|---|---|
| Founded | 1965 | 1888 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 183.5B | 173.2B |
| IPO Year | 1994 | 2007 |
Fundamental Metrics
Financial Performance| Metric | ADI | ABT |
|---|---|---|
| Price | $405.40 | $100.47 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 34 | 28 |
| Target Price | ★ $471.34 | $120.72 |
| AVG Volume (30 Days) | 2.6M | ★ 6.0M |
| Earning Date | 11-24-2026 | 10-21-2026 |
| Dividend Yield | 1.11% | ★ 2.46% |
| EPS Growth | ★ 39.02 | N/A |
| EPS | ★ 6.83 | 0.61 |
| Revenue | $6,200,942,000.00 | ★ $44,328,000,000.00 |
| Revenue This Year | $36.96 | $13.24 |
| Revenue Next Year | $21.14 | $8.62 |
| P/E Ratio | ★ $58.40 | $169.02 |
| Revenue Growth | ★ 21.41 | 5.67 |
| 52 Week Low | $223.47 | $81.97 |
| 52 Week High | $449.52 | $132.03 |
Technical Indicators
Market Signals| Indicator | ADI | ABT |
|---|---|---|
| Relative Strength Index (RSI) | 56.07 | 43.67 |
| Support Level | $375.59 | $96.54 |
| Resistance Level | $432.70 | $104.19 |
| Average True Range (ATR) | 11.61 | 2.73 |
| MACD | -2.09 | 0.50 |
| Stochastic Oscillator | 50.47 | 36.98 |
Price Performance
Historical ComparisonAbout ADI Analog Devices Inc.
Analog Devices is a leading analog, mixed-signal, and digital-signal processing chipmaker. The firm has a significant market share lead in converter chips, which are used to translate analog signals to digital and vice versa. The company serves tens of thousands of customers; more than half of its chip sales are to industrial and automotive end markets. ADI's chips are also incorporated into wireless infrastructure equipment.
About ABT Abbott Laboratories
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.